CINCINNATI - A plaintiff's claim that PLIVA Inc. failed to add a 2004 warning from the Reglan label to its label for generic metoclopramide is not preempted, a panel of the Sixth Circuit U.S. Court of Appeals said March 13 in what it described as a question of first impression in the circuit (Eleanor Fulgenzi v. PLIVA, Inc., No. 12-3504, 6th Cir.; 2013 U.S. App. LEXIS 4961)....(read more)![]()
↧